Advanced prostate cancer – lessons from the past for success in the future

This report is based on a workshop seminar held during the 8th Annual Meeting of the British Uro-oncology Group in York last September. The workshop contrasted the well-known clinical trial failures of a number of promising drugs for castration-resistant prostate cancer (CRPC) before 2009, with the rush of positive late-phase trials reported over the past two years.

Read the full article.

Add yours ↓
Web design and marketing agency Leamington Spa